Drug dependence associated with triptans and ergot derivatives: A case/non-case study

European Journal of Clinical Pharmacology

Volumn 66, Issue 4, 2010, Pages 413-417

  Beau Salinas, Frédérique ^a   Jonville Béra, Annie Pierre ^a   Cissoko, Haware ^a   Bensouda Grimaldi, Lamiae ^a,b   Autret Leca, Elisabeth ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Case non case study; Drug dependence; Ergot derivatives; Medication overuse; Migraine treatment; Triptans

Indexed keywords

ALMOTRIPTAN; AMOXICILLIN; BENZODIAZEPINE DERIVATIVE; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOT DERIVATIVE; ERGOTAMINE; NARATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN; OXAZOLIDINONE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ARTICLE; CASE STUDY; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG SURVEILLANCE PROGRAM; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNSPECIFIED SIDE EFFECT; ADDICTION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLAVICEPS; MIGRAINE; RISK;

CLAVICEPS; DIHYDROERGOTAMINE; ERGOTAMINE; HUMANS; MIGRAINE DISORDERS; OXAZOLIDINONES; PIPERIDINES; PYRROLIDINES; RISK; SUBSTANCE-RELATED DISORDERS; SUMATRIPTAN; TRYPTAMINES;

EID: 77953921426     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0769-6     Document Type: Article

References (38)

1. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270
2. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57:1694-1698
3. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011-1014
4. Silberstein SD, Liu D (2002) Drug overuse and rebound headache. Curr Pain Headache Rep 6:240-247
5. Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt IW, Ringelstein EB (1999) Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 22:201-206
6. Gaist D, Tsiropoulos I, Sindrup SH, Hallas J, Rasmussen BK, Kragstrup J, Gram LF (1998) Inappropriate use of sumatriptan: population-based register and interview study. BMJ 316:1352-1353
7. Gaist D (1999) Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalagia 19:735-761
8. Dowson A (1999) Drug-induced headaches. Lancet 354:254-255
9. Osborne MJ, Austin RCT, Dawson KJ, Lange L (1994) Drug points: is there a problem with long term use of sumatriptan in acute migraine? BMJ 308:113
10. Goadsby PJ (1998) Sumatriptan is not the only analgesic used inappropriately. BMJ 317:1016
11. Silberstein SD (2005) Chronic daily headache. J Am Osteopath Assoc 105:23S-29S
12. Lantéri-Minet P, Auray JP, el Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143-149
13. Silberstein SB, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gôbel H, Lainez MJA, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ (2005) The international classification of headache disorders, 2nd edition (ICHD-II) - revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25:460-465
14. Calabresi P, Cupini LM (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26:62-68
15. Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25:519-522
16. Kaube H, May A, Diener HC (1994) Sumatriptan. BMJ 308:1573-1574
17. Limmroth V, Kazarawa Z, Fritsche G, Diener HC (1999) Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 353:378
18. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC
19. Fuh JL, Wang SJ, Lu SR, Juang KD (2005) Does medication overuse headache represent a behavior of dependence? Pain 119:49-55
20. Hauben M, Zhou X (2003) Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 26:159-186
21. Evans SJW, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10:483-486
22. Meyboom RHB, Egberts ACG, Edwards IR, Hekster YA, de Koning FHP, Gribnau FWJ (1997) Principles of signal detection in pharmacovigilance. Drug Saf 16:355-365
23. Schweizer E, Rickels K (1998) Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand 393(Suppl):95-101
24. Liautard C, Correa Nunes AM, Vial T, Chatillon F, Guy C, Ollagnier M, Descotes J (2002) Low-molecular weight heparins and thrombocytosis. Ann Pharmacother 36:1351-1354
25. Bareille MP, Montastruc JL, Lapeyre-Mestre M (2001) Atteintes hépatiques et médicaments anti-inflammatoires non stéroïdiens: étude cas/non cas dans la banque Nationale de Pharmacovigilance. Therapie 56:51-55
26. Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Bégaud B (1997) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 44:513-518
27. Desboeuf K, Lapeyre-Mestre M, Montastruc JL (1998) Risk of gastrointestinal haemorrhage with calcium antagonists. Br J Clin Pharmacol 46:87-89
28. Petit A, Piednoir D, Germain ML, Trenque T (2003) Hyperprolactiné mies d'origine médicamenteuse: étude cas/non-cas dans la banque nationale de pharmacovigilance. Therapie 58:159-163
29. Ottervanger JP, Valkenburg HA, Grobbee DE, Stricker BHC (1996) Pattern of sumatriptan use and overuse in general practice. Eur J Clin Pharmacol 50:353-355
30. Perearnau P, Vuillemet F, Schick J, Weill G (2006) Modes de prescription et de consommation des triptans en Alsace: un mésusage fréquent mais évitable. Rev Neurol 162:347-357
31. Roussel H, Lo Re G, Honorat C, Alonso M, Sciortino V (2006) Prescription des triptans en médecine de ville dans la région Midi- Pyrénées: indications, contre-indications, abus médicamenteux. Therapie 61:507-516
32. Géraud G, Keywood C, Senard JM (2003) Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 43:376-388
33. Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E (2006) Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalagia 26:187-193
34. Radat F, Créac'h C, Guegan-Massardier E, Mick G, Guy N, Fabre N, Giraud P, Nachit-Ouinekh F, Lantéri-Minet M (2008) Behavioral dependence in patients with medication overuse headache: a crosssectional study in consulting patients using the DSM-IV criteria. Headache 48:1026-1036
35. Créac'h C, Radat F, Mick G, Guegan-Massardier E, Giraud P, Guy N, Fabre N, Nachit-Ouinekh F, Lantéri-Minet M (2009) One or several types of triptan overuse headaches? Headache 49:519-528
36. Katsarava Z, Diener HC, Limmroth V (2001) Medication overuse headache. A focus on analgesics, ergot alkaloids and triptans. Drug Saf 24:921-927
37. Relja G, Granato A, Bratina A, Antonello RM, Zorzon M (2006) Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 26:589-595
38. Meskunas CA, Tepper J, Rapoport AM, Sheftell FD, Bigal ME (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46:766-772